These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

950 related items for PubMed ID: 9445186

  • 21. Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies.
    Hoffman PC, Masters GA, Drinkard LC, Krauss SA, Samuels BL, Golomb HM, Vokes EE.
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):11-5. PubMed ID: 8677441
    [Abstract] [Full Text] [Related]

  • 22. A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer.
    Strauss GM, Lynch TJ, Elias AD, Jacobs C, Kwiatkowski DJ, Shulman LN, Carey RW, Grossbard ML, Jauss S, Sugarbaker DJ.
    Semin Oncol; 1995 Aug; 22(4 Suppl 9):70-4. PubMed ID: 7544029
    [Abstract] [Full Text] [Related]

  • 23. Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer.
    Shirinian M, Lee JS, Dhingra HH, Greenberg J, Hong WK.
    Semin Oncol; 1992 Feb; 19(1 Suppl 1):49-53. PubMed ID: 1329212
    [Abstract] [Full Text] [Related]

  • 24. Ifosfamide, carboplatin, and etoposide plus granulocyte-macrophage colony-stimulating factor: a phase I study with apparent activity in non-small-cell lung cancer.
    Krigel RL, Palackdharry CS, Padavic K, Haas N, Kilpatrick D, Langer C, Comis R.
    J Clin Oncol; 1994 Jun; 12(6):1251-8. PubMed ID: 8201386
    [Abstract] [Full Text] [Related]

  • 25. Study of either ifosfamide or teniposide compared to a standard chemotherapy for extensive disease small cell lung cancer: an Eastern Cooperative Oncology Group randomized study (E1588).
    Ettinger DS, Finkelstein DM, Ritch PS, Lincoln ST, Blum RH, Eastern Cooperative Oncology Group.
    Lung Cancer; 2002 Sep; 37(3):311-8. PubMed ID: 12234701
    [Abstract] [Full Text] [Related]

  • 26. A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma.
    Mok TS, Wong H, Zee B, Yu KH, Leung TW, Lee TW, Yim A, Chan AT, Yeo W, Chak K, Johnson P.
    Cancer; 2002 Oct 01; 95(7):1511-9. PubMed ID: 12237920
    [Abstract] [Full Text] [Related]

  • 27. Experience with ifosfamide and etoposide combination chemotherapy in extensive-disease small-cell lung cancer.
    Wu MF, Perng RP, Chen YM, Liu JM, Yang SL, Whang-Peng J.
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Aug 01; 60(2):67-73. PubMed ID: 9360330
    [Abstract] [Full Text] [Related]

  • 28. Ifosfamide, cisplatin and etoposide (ICE) combined chemotherapy with recombinant human granulocyte colony-stimulating factor support in small cell lung cancer.
    Hastürk S, Kurt B, Kocabas A, Orüç O, Burgut R.
    J Chemother; 1997 Feb 01; 9(1):66-71. PubMed ID: 9106021
    [Abstract] [Full Text] [Related]

  • 29. Etoposide-cisplatin and thoracic radiation therapy salvage of incomplete responders to a noncisplatin induction regimen for limited and extensive small-cell carcinoma of the lung.
    Shaw EG, Frytak S, Eagan RT, Richardson RL, Creagan ET, Jett JR, Foote RL, Su JQ, Schaid DJ, Lee RE.
    Am J Clin Oncol; 1996 Apr 01; 19(2):154-8. PubMed ID: 8610640
    [Abstract] [Full Text] [Related]

  • 30. Phase II study of daily oral etoposide plus ifosfamide plus cisplatin for previously treated recurrent small-cell lung cancer: a Hoosier Oncology Group Trial.
    Faylona EA, Loehrer PJ, Ansari R, Sandler AB, Gonin R, Einhorn LH.
    J Clin Oncol; 1995 May 01; 13(5):1209-14. PubMed ID: 7738623
    [Abstract] [Full Text] [Related]

  • 31. Ifosfamide in the treatment of small cell lung cancer.
    Ettinger DS.
    Semin Oncol; 1996 Jun 01; 23(3 Suppl 6):2-6. PubMed ID: 8677443
    [Abstract] [Full Text] [Related]

  • 32. Phase I/II study of cisplatin, ifosfamide and irinotecan with rhG-CSF support in patients with stage IIIB and IV non-small-cell lung cancer.
    Fujita A, Takabatake H, Tagaki S, Sekine K.
    Cancer Chemother Pharmacol; 2000 Jun 01; 45(4):279-83. PubMed ID: 10755315
    [Abstract] [Full Text] [Related]

  • 33. A phase II study of ifosfamide, cisplatin, etoposide in patients with advanced non-small cell lung cancer: a preliminary report.
    Shepherd FA, Goss PE, Latreille J, Stewart D, Logan D, Evans WK, Maroun J, Warner E.
    Semin Oncol; 1990 Apr 01; 17(2 Suppl 4):19-23. PubMed ID: 2159185
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Preliminary study of efficacy of intravenous cisplatin plus oral etoposide in small cell lung cancer.
    Chewaskulyong B, Thongprasert S.
    J Med Assoc Thai; 1998 Jan 01; 81(1):37-41. PubMed ID: 9470320
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 48.